Technology

MorphoSys

$29.26
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.67 (+6.05%) Today
$0.00 (0.00%) As of 9:00 PM UTC after-hours

Why Robinhood?

You can buy or sell MorphoSys and other stocks, options, and ETFs commission-free!

About MOR

MorphoSys AG engages in the development of antibodies for therapeutic, diagnostics, and research applications. It operates through the Proprietary Development and Partnered Discovery segments. The Proprietary Development segment combines proprietary research and development of therapeutic compounds. The Partnered Discovery segment offers technologies to make human antibody-based therapeutics on behalf of partners in the pharmaceutical industry. The company was founded by Andreas Pluckthun and Simon E. Moroney in July 1992 and is headquartered in Planegg, Germany. The listed name for MOR is MorphoSys AG American Depositary Shares.

CEO
Jean-Paul Kress
Employees
426
Headquarters
Planegg, Bayern (Bavaria)
Founded
1992
Market Cap
4.00B
Price-Earnings Ratio
128.09
Dividend Yield
—
Average Volume
32.64K
High Today
$29.44
Low Today
$29.00
Open Price
$29.19
Volume
53.67K
52 Week High
$35.73
52 Week Low
$18.21

Collections

MOR Earnings

-$2.36
$0.67
$3.71
$6.74
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Available Mar 15, After Hours

You May Also Like

XT
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure